估算推荐心理治疗对抑郁症的最小值得差异:观察性研究
该研究通过在线调查英国和美国526名参与者,估算心理治疗相比无治疗在2个月后反应率的最小值得差异(SWD)。中重度抑郁症状未治疗且愿意考虑心理治疗者的SWD中位数为20%(四分位距10-35%),与抗抑郁药SWD相似。当前经验支持的心理治疗反应率15%仅足以让三分之一的人启动治疗。
要点
- 中重度抑郁未治疗者心理治疗SWD中位数为20%反应率差异。
- 心理治疗SWD与抗抑郁药SWD(20%)无实质差异。
- 当前15%反应率仅足以让三分之一患者启动心理治疗。
核心结论
- 心理治疗相比无治疗的SWD中位数为20%反应率差异,与抗抑郁药相似。
- 当前经验支持的心理治疗反应率15%仅足以让三分之一患者启动治疗。
研究设计与样本
- 观察性研究,通过Prolific在线平台于2025年1月在英国和美国招募526名参与者。
- 主要分析中重度抑郁症状未治疗且愿意考虑心理治疗者87人,另查询随机子集复现抗抑郁药SWD。
主要发现
- 中重度抑郁症状未治疗且愿意考虑心理治疗者SWD中位数为20%(四分位距10-35%)。
- 抗抑郁药SWD中位数为20%(四分位距10-30%;n=104),与心理治疗相似。
- 6%参与者表示即使100%治疗反应也不会启动心理治疗。
- 参与者特征与SWD无有意义的关联。
关键数值与推荐
- 心理治疗SWD中位数20%(四分位距10-35%),对象为中重度抑郁症状未治疗且愿意考虑心理治疗者。
- 抗抑郁药SWD中位数20%(四分位距10-30%;n=104)。
- 当前经验支持的心理治疗反应率15%足以让三分之一的人启动治疗,但三分之二期望更大获益或更少负担。
临床怎么用
- 临床决策中应关注患者个体价值判断和偏好对治疗启动的影响。
- 心理治疗与抗抑郁药的SWD相似,可向患者说明两者在患者感知重要性上无实质差异。
局限性
- 研究结果需在不同地理位置的多样化样本中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The smallest worthwhile difference (SWD) represents the smallest beneficial effect of an intervention that patients deem worthwhile given the harms, expenses and inconveniences of the intervention. The SWD facilitates interpretation of the patient-perceived importance of intervention effects. We previously estimated the SWD for antidepressants for depression, but the SWD for psychotherapy remains unknown. AIMS: To estimate the SWD of recommended psychotherapies for depression compared with no treatment. METHOD: We estimated the SWD through a patient required difference in response rates between psychotherapy and no treatment after 2 months. We recruited using Prolific, an online cross-sectional survey platform, in the UK and USA in January 2025. We also queried a random subset of respondents to replicate our previous SWD estimation for antidepressants. RESULTS: In the primary study, we recruited 526 participants (mean age: 36.7 years (s.d. = 12.5); 54% women and 61% White individuals). Of these, 6% reported that they would not initiate psychotherapy with a 100% treatment response. For those willing to initiate psychotherapy, 87 reported moderate-to-severe depressive symptoms but were not in treatment, 184 were in treatment and 131 reported absent-to-mild symptoms with or without previous treatment. The median SWD for people with moderate-to-severe depressive symptoms, not in treatment and willing to consider psychotherapies was a 20% (interquartile range: 10-35%) difference in response rates comparing psychotherapy with no treatment. This was similar to the SWD for antidepressant drugs (SWD = 20%, interquartile range: 10-30%; n = 104). Participant characteristics were not meaningfully associated with the SWD. CONCLUSIONS: Current empirically supported psychotherapy response rates of 15% were sufficient for one in three people to initiate psychotherapy given the burdens, but two in three expected greater treatment benefits or fewer burdens. The SWD for psychotherapy was not materially different from the estimated SWD for antidepressants. Individual patient value judgements and preferences merit greater attention. These findings should be replicated with diverse samples from different geographical locations.
引用
- Sahker E, Luo Y, Omae K, et al. Estimating the smallest worthwhile difference of recommended psychotherapies for depression: observational study. Br J Psychiatry. 2025. PMID: 41208379. doi:10.1192/bjp.2025.10453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。